{"id":"W2789843372","doi":"10.2147/opth.s152841","title":"Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"Clinical ophthalmology","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Santen; Shire; National Institutes of Health; Omeros Corporation; Valeant Pharmaceuticals International","keywords":"Medicine; Placebo; Discontinuation; Randomized controlled trial; Eye drop; Adverse effect; Artificial tears; Anesthesia; Ophthalmology; Surgery; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001953015,0.00110651,0.002599811,0.0003404532,0.0003991434,0.001002449,0.0007293591,0.001253003,0.004929059],"category_scores_gemma":[0.001745777,0.0004748914,0.001836534,0.0004199735,0.0007326151,0.0006650691,0.0002902024,0.001718591,0.0004747923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006574152,"about_ca_system_score_gemma":0.001186065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007111853,"about_ca_topic_score_gemma":0.002288738,"domain_scores_codex":[0.9991717,0.0004721361,0.00006280038,0.0001050127,0.00008519529,0.0001032327],"domain_scores_gemma":[0.9990798,0.0002650176,0.0003405896,0.00004951277,0.00006723963,0.0001977012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9742756,0.003930388,0.0007603931,0.00142764,0.0009021233,0.00003529002,0.00004560175,0.0001391164,0.001974621,0.00007295435,0.0005476275,0.01588852],"study_design_scores_gemma":[0.9399198,0.05628479,0.002224938,0.00006751103,0.0005156753,0.00002671117,0.00002115591,0.0002260669,0.0002512076,0.0000579378,0.0003948213,0.000009475196],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778402,0.0138548,0.0007406901,0.0005993556,0.0003648488,0.003973021,0.0007636382,0.0001479752,0.00171538],"genre_scores_gemma":[0.9850745,0.005014595,0.001508072,0.0009248654,0.0003989932,0.005184249,0.0005756484,0.00001813204,0.001300912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004929059,"threshold_uncertainty_score":0.01648939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05955013936892159,"score_gpt":0.4557994863710338,"score_spread":0.3962493470021122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}